The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Safonova O.O.

Peoples’ Friendship University of Russia

Maksimkin D.A.

Peoples’ Friendship University of Russia

Chepurnoy A.G.

Russian Peoples’ Friendship University

Shugushev Z.Kh.

Peoples’ Friendship University of Russia

Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions

Authors:

Safonova O.O., Maksimkin D.A., Chepurnoy A.G., Shugushev Z.Kh.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6): 554‑559

DOI: 10.17116/kardio202215061554

Read: 2791 times

Contact the author
Table of contents

DRUG-ELUTING BALLOON CATHETERS IN THE TREATMENT OF LEFT MAIN CORONARY ARTERY BIFURCATION LESIONS
DRUG-ELUTING BALLOON CATHETERS IN THE TREATMENT OF LEFT MAIN CORONARY ARTERY BIFURCATION LESIONS

To cite this article:

Safonova OO, Maksimkin DA, Chepurnoy AG, Shugushev ZKh. Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6):554‑559. (In Russ.)
https://doi.org/10.17116/kardio202215061554

 
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Effi­cacy of drug-eluting balloon catheters in the treatment of left main coro­nary artery bifu­rcation stenosis: a 12-month follow-up. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):666-673
Abstract:

This review is devoted to drug-coated balloon catheters in percutaneous coronary interventions. There are numerous data confirming the efficacy and safety of their use in patients with in-stent restenosis, as well as in lesions of small arteries. Evidence base for their use in patients with bifurcation coronary stenosis remains sparse. Nevertheless, modern studies demonstrate no advantages of double-stent bifurcation stenting over single-stent methods with drug-eluting balloon catheters including patients with bifurcation coronary stenosis. At the same time, there are unresolved issues of selecting patients for such interventions, technical aspects of stenting, feasibility of intravascular imaging methods and insufficient information about long-term results of treatment of such patients.

Keywords:

left main coronary artery bifurcation lesions
drug-eluting balloon catheters

Authors:

Safonova O.O.

Peoples’ Friendship University of Russia

Maksimkin D.A.

Peoples’ Friendship University of Russia

Chepurnoy A.G.

Russian Peoples’ Friendship University

Shugushev Z.Kh.

Peoples’ Friendship University of Russia

Received:

17.01.2022

Accepted:

10.02.2022

Close metadata

References:

  1. Angelini P. Coronary artery anomalies--current clinical issues: definitions, classification, incidence, clinical relevance, and treatment guidelines. Tex Heart Inst J. 2002;29(4):271-278.  https://doi.org/10.1016/j.repc.2017.06.019
  2. Gruentzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61-68.  https://doi.org/10.1056/NEJM197907123010201
  3. Thomas M, Hildick-Smith D, Louvard Y, et al. Percutaneous coronary intervention for bifurcation disease. A consensus view from the first meeting of the European Bifurcation Club. Euro Intervention. 2006;2(2):149-153.  https://doi.org/10.4244/EIJV10I5A97
  4. Lassen JF, Burzotta F, Banning AP, et al. Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club. Euro Intervention. 2018;13(13):1540-1553. https://doi.org/10.4244/EIJ-D-17-00622
  5. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619. https://doi.org/10.1093/eurheartj/ehu278
  6. Park TK, Park YH, Song YB, et al. Long-Term Clinical Outcomes of True and Non-True Bifurcation Lesions According to Medina Classification- Results from the COBIS (Coronary BIfurcation Stent) II Registry. Circ J. 2015;79(9):1954-1962. https://doi.org/10.1253/circj.CJ-15-0264
  7. Speck U, Scheller B, Hamm B. Drug-coated balloons for restenosis prophylaxis. Rofo. 2014;186(4):348-358.  https://doi.org/10.1055/s-0033-1350523
  8. Navarese EP, Austin D, Gurbel PA, et al. Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. Clin Res Cardiol. 2013;102(4):279-287.  https://doi.org/10.1007/s00392-012-0532-3
  9. Kaule S, Minrath I, Stein F, et al. Correlating coating characteristics with the performance of drug-coated balloons — a comparative in vitro investigation of own established hydrogel- and ionic liquid-based coating matrices. PLoS One. 2015;10(3):e0116080. https://doi.org/10.1371/journal.pone.0116080
  10. Wöhrle J. Drug-coated balloons for coronary and peripheral interventional procedures. Curr Cardiol Rep. 2012;14(5):635-641.  https://doi.org/10.1007/s11886-012-0290-x
  11. Jackson D, Tong D, Layland J. A review of the coronary applications of the drug coated balloon. Int J Cardiol. 2017;226:77-86.  https://doi.org/10.1016/j.ijcard.2016.09.045
  12. Verheye S, Vrolix M, Kumsars I, et al. The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes. JACC Cardiovasc Interv. 2017;10(20):2029-2037. https://doi.org/10.1016/j.jcin.2017.06.021
  13. Kleber FX, Schulz A, Waliszewski M, et al. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiol. 2015;104(3):217-225.  https://doi.org/10.1007/s00392-014-0775-2
  14. Burzotta F, Lassen JF, Lefèvre T, et al. Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club. Euro Intervention. 2021;16(16):1307-1317. https://doi.org/10.4244/EIJ-D-20-00169
  15. Kleber FX, Mathey DG, Rittger H, Scheller B. German Drug-eluting Balloon Consensus Group. How to use the drug-eluting balloon: recommendations by the German consensus group. Euro Intervention. 2011;7 suppl K:K125-128.  https://doi.org/10.4244/EIJV7SKA2
  16. Cortese B, Berti S, Biondi-Zoccai G, et al. Italian Society of Interventional Cardiology. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv. 2014;83(3):427-435.  https://doi.org/10.1002/ccd.25149
  17. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv. 2008;71(5):629-635.  https://doi.org/10.1002/ccd.21452
  18. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. Euro Intervention. 2011;7 suppl .K:K61-65.  https://doi.org/10.4244/EIJV7SKA11
  19. Belkacemi A, Agostoni P, Voskuil M, Stella PR. Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study. Euro Intervention. 2011;7 suppl K:K66-69.  https://doi.org/10.4244/EIJV7SKA12
  20. Kelsch B, Scheller B, Biedermann M, et al. Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol. 2011;46(4):255-263.  https://doi.org/10.1097/RLI.0b013e31820577df
  21. Byrne RA, Joner M, Alfonso F, Kastrati A. Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol. 2014;11(1):13-23.  https://doi.org/10.1038/nrcardio.2013.165
  22. Worthley S, Hendriks R, Worthley M, et al. Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study. Cardiovasc Revasc Med. 2015;16(7):413-417.  https://doi.org/10.1016/j.carrev.2015.07.009
  23. Berland J, Lefèvre T, Brenot P, et al. DEBSIDE trial investigators. DANUBIO — a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial. Euro Intervention. 2015;11(8):868-876.  https://doi.org/10.4244/EIJV11I8A177
  24. Cortese B, Piraino D, Buccheri D, Alfonso F. Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientific data. Int J Cardiol. 2016;220:589-594.  https://doi.org/10.1016/j.ijcard.2016.06.079
  25. Patel S, Svermova T, Burke-Gaffney A, Bogle RG. Drug-eluting balloons with provisional bail-out or adjunctive stenting in de novo coronary artery lesions-a systematic review and meta-analysis. Cardiovasc Diagn Ther. 2018;8(2):121-136.  https://doi.org/10.21037/cdt.2017.10.09
  26. Jing QM, Zhao X, Han YL, et al. A drug-eluting Balloon for the treatment of coronary bifurcation lesions in the side branch: a prospective multicenter randomized (BEYOND) clinical trial in China. Chin Med J (Engl). 2020;133(8):899-908.  https://doi.org/10.1097/CM9.0000000000000743
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.